XML 46 R20.htm IDEA: XBRL DOCUMENT v2.4.1.9
Collaborative Agreements (Details 2) (USD $)
3 Months Ended 9 Months Ended 1 Months Ended 40 Months Ended 1 Months Ended
Mar. 31, 2015
Mar. 31, 2014
Mar. 31, 2015
Mar. 31, 2014
Nov. 30, 2011
item
Oct. 31, 2013
Dec. 31, 2012
Nov. 30, 2009
Sep. 30, 2009
Dec. 31, 2012
item
May 31, 2013
item
Collaborative Agreements disclosures                      
Amount of arrangement consideration included in license and milestone fees $ 5,078,000imgn_LicenseAndMilestoneFees $ 305,000imgn_LicenseAndMilestoneFees $ 52,729,000imgn_LicenseAndMilestoneFees $ 39,150,000imgn_LicenseAndMilestoneFees              
Amgen | Future Technological Improvements                      
Collaborative Agreements disclosures                      
Remaining arrangement consideration to be recognized as license revenue 430,000us-gaap_DeferredRevenue
/ us-gaap_CounterpartyNameAxis
= imgn_AmgenMember
/ imgn_MilestonePaymentsCategoryAxis
= imgn_FutureTechnologicalImprovementsMember
  430,000us-gaap_DeferredRevenue
/ us-gaap_CounterpartyNameAxis
= imgn_AmgenMember
/ imgn_MilestonePaymentsCategoryAxis
= imgn_FutureTechnologicalImprovementsMember
               
Amgen | Development and Commercialization License                      
Collaborative Agreements disclosures                      
Potential milestone payments           34,000,000imgn_CollaborativeArrangementMilestonePaymentsPotential
/ us-gaap_CounterpartyNameAxis
= imgn_AmgenMember
/ us-gaap_TypeOfArrangementAxis
= imgn_DevelopmentAndCommercializationLicenseMember
         
Estimated utilization period after commercialization     10 years                
Discount rate (as a percent)     13.00%us-gaap_FairValueInputsDiscountRate
/ us-gaap_CounterpartyNameAxis
= imgn_AmgenMember
/ us-gaap_TypeOfArrangementAxis
= imgn_DevelopmentAndCommercializationLicenseMember
               
Estimated term of development and commercialization license     25 years                
Amgen | Development and Commercialization License | Phase II clinical trial                      
Collaborative Agreements disclosures                      
Potential milestone payments 3,000,000imgn_CollaborativeArrangementMilestonePaymentsPotential
/ us-gaap_CounterpartyNameAxis
= imgn_AmgenMember
/ imgn_DevelopmentPhaseAxis
= imgn_PhaseIIClinicalTrialMember
/ us-gaap_TypeOfArrangementAxis
= imgn_DevelopmentAndCommercializationLicenseMember
  3,000,000imgn_CollaborativeArrangementMilestonePaymentsPotential
/ us-gaap_CounterpartyNameAxis
= imgn_AmgenMember
/ imgn_DevelopmentPhaseAxis
= imgn_PhaseIIClinicalTrialMember
/ us-gaap_TypeOfArrangementAxis
= imgn_DevelopmentAndCommercializationLicenseMember
               
Amgen | Development and Commercialization License | IND application effective                      
Collaborative Agreements disclosures                      
Potential milestone payments 1,000,000imgn_CollaborativeArrangementMilestonePaymentsPotential
/ us-gaap_CounterpartyNameAxis
= imgn_AmgenMember
/ imgn_DevelopmentPhaseAxis
= imgn_RegulatoryMilestoneInvestigationalNewDrugApplicationEffectiveMember
/ us-gaap_TypeOfArrangementAxis
= imgn_DevelopmentAndCommercializationLicenseMember
  1,000,000imgn_CollaborativeArrangementMilestonePaymentsPotential
/ us-gaap_CounterpartyNameAxis
= imgn_AmgenMember
/ imgn_DevelopmentPhaseAxis
= imgn_RegulatoryMilestoneInvestigationalNewDrugApplicationEffectiveMember
/ us-gaap_TypeOfArrangementAxis
= imgn_DevelopmentAndCommercializationLicenseMember
               
Fee received per license         1,000,000imgn_ProceedsFromCollaboratorsPerLicense
/ us-gaap_CounterpartyNameAxis
= imgn_AmgenMember
/ imgn_DevelopmentPhaseAxis
= imgn_RegulatoryMilestoneInvestigationalNewDrugApplicationEffectiveMember
/ us-gaap_TypeOfArrangementAxis
= imgn_DevelopmentAndCommercializationLicenseMember
           
Number of compounds under development and commercialization licenses         2imgn_CollaborativeArrangementNumberOfCompoundsUnderDevelopmentAndCommercializationLicenses
/ us-gaap_CounterpartyNameAxis
= imgn_AmgenMember
/ imgn_DevelopmentPhaseAxis
= imgn_RegulatoryMilestoneInvestigationalNewDrugApplicationEffectiveMember
/ us-gaap_TypeOfArrangementAxis
= imgn_DevelopmentAndCommercializationLicenseMember
           
Number of milestone payments received         2imgn_CollaborativeArrangementNumberOfMilestonePaymentsPaid
/ us-gaap_CounterpartyNameAxis
= imgn_AmgenMember
/ imgn_DevelopmentPhaseAxis
= imgn_RegulatoryMilestoneInvestigationalNewDrugApplicationEffectiveMember
/ us-gaap_TypeOfArrangementAxis
= imgn_DevelopmentAndCommercializationLicenseMember
           
Amgen | Development and Commercialization License | Development milestones                      
Collaborative Agreements disclosures                      
Potential milestone payments           9,000,000imgn_CollaborativeArrangementMilestonePaymentsPotential
/ us-gaap_CounterpartyNameAxis
= imgn_AmgenMember
/ imgn_MilestonePaymentsCategoryAxis
= imgn_DevelopmentMilestonesMember
/ us-gaap_TypeOfArrangementAxis
= imgn_DevelopmentAndCommercializationLicenseMember
         
Amgen | Development and Commercialization License | Regulatory milestones                      
Collaborative Agreements disclosures                      
Potential milestone payments           20,000,000imgn_CollaborativeArrangementMilestonePaymentsPotential
/ us-gaap_CounterpartyNameAxis
= imgn_AmgenMember
/ imgn_MilestonePaymentsCategoryAxis
= imgn_RegulatoryMilestonesMember
/ us-gaap_TypeOfArrangementAxis
= imgn_DevelopmentAndCommercializationLicenseMember
         
Amgen | Development and Commercialization License | Sales milestones                      
Collaborative Agreements disclosures                      
Potential milestone payments           5,000,000imgn_CollaborativeArrangementMilestonePaymentsPotential
/ us-gaap_CounterpartyNameAxis
= imgn_AmgenMember
/ imgn_MilestonePaymentsCategoryAxis
= imgn_SalesMilestonesMember
/ us-gaap_TypeOfArrangementAxis
= imgn_DevelopmentAndCommercializationLicenseMember
         
Amgen | Development and Commercialization License | Exclusive license                      
Collaborative Agreements disclosures                      
Amount of arrangement consideration included in license and milestone fees       2,200,000imgn_LicenseAndMilestoneFees
/ us-gaap_CounterpartyNameAxis
= imgn_AmgenMember
/ us-gaap_TypeOfArrangementAxis
= imgn_DevelopmentAndCommercializationLicenseMember
/ imgn_TypeOfLicenseAxis
= imgn_ExclusiveDevelopmentAndCommercializationLicenseMember
             
Number of single-target licenses     4imgn_NumberOfSingleTargetLicenses
/ us-gaap_CounterpartyNameAxis
= imgn_AmgenMember
/ us-gaap_TypeOfArrangementAxis
= imgn_DevelopmentAndCommercializationLicenseMember
/ imgn_TypeOfLicenseAxis
= imgn_ExclusiveDevelopmentAndCommercializationLicenseMember
            3imgn_NumberOfSingleTargetLicenses
/ us-gaap_CounterpartyNameAxis
= imgn_AmgenMember
/ us-gaap_TypeOfArrangementAxis
= imgn_DevelopmentAndCommercializationLicenseMember
/ imgn_TypeOfLicenseAxis
= imgn_ExclusiveDevelopmentAndCommercializationLicenseMember
 
Fee received per license             1,000,000imgn_ProceedsFromCollaboratorsPerLicense
/ us-gaap_CounterpartyNameAxis
= imgn_AmgenMember
/ us-gaap_TypeOfArrangementAxis
= imgn_DevelopmentAndCommercializationLicenseMember
/ imgn_TypeOfLicenseAxis
= imgn_ExclusiveDevelopmentAndCommercializationLicenseMember
1,000,000imgn_ProceedsFromCollaboratorsPerLicense
/ us-gaap_CounterpartyNameAxis
= imgn_AmgenMember
/ us-gaap_TypeOfArrangementAxis
= imgn_DevelopmentAndCommercializationLicenseMember
/ imgn_TypeOfLicenseAxis
= imgn_ExclusiveDevelopmentAndCommercializationLicenseMember
1,000,000imgn_ProceedsFromCollaboratorsPerLicense
/ us-gaap_CounterpartyNameAxis
= imgn_AmgenMember
/ us-gaap_TypeOfArrangementAxis
= imgn_DevelopmentAndCommercializationLicenseMember
/ imgn_TypeOfLicenseAxis
= imgn_ExclusiveDevelopmentAndCommercializationLicenseMember
   
Fee received on conversion of non-exclusive license agreement to an exclusive license           500,000imgn_ProceedsReceivedOnConversionOfLicenseAgreement
/ us-gaap_CounterpartyNameAxis
= imgn_AmgenMember
/ us-gaap_TypeOfArrangementAxis
= imgn_DevelopmentAndCommercializationLicenseMember
/ imgn_TypeOfLicenseAxis
= imgn_ExclusiveDevelopmentAndCommercializationLicenseMember
         
Amgen | Development and Commercialization License | Non-exclusive license                      
Collaborative Agreements disclosures                      
Number of single-target licenses                     1imgn_NumberOfSingleTargetLicenses
/ us-gaap_CounterpartyNameAxis
= imgn_AmgenMember
/ us-gaap_TypeOfArrangementAxis
= imgn_DevelopmentAndCommercializationLicenseMember
/ imgn_TypeOfLicenseAxis
= imgn_NonExclusiveDevelopmentAndCommercializationLicenseMember
Fee received per license                     $ 500,000imgn_ProceedsFromCollaboratorsPerLicense
/ us-gaap_CounterpartyNameAxis
= imgn_AmgenMember
/ us-gaap_TypeOfArrangementAxis
= imgn_DevelopmentAndCommercializationLicenseMember
/ imgn_TypeOfLicenseAxis
= imgn_NonExclusiveDevelopmentAndCommercializationLicenseMember